Table 3.
Comparison of the study’ variables at the baseline (phase I) and the end of the second phase in the lavender and control groups
| Parameters | Lavender Group (Mean ± SD) | Control Group (Mean ± SD) | ||||||
|---|---|---|---|---|---|---|---|---|
| Phase I | Phase II | Change | P- value | Baseline | Phase 2 | Change | P-value | |
| SBP |
140.56 ± 16.53 |
133.16 ± 12.20 | - 7.4 ± 12.34 | 0.021 | 142.32 ± 12.36 |
137.09 ± 10.04 |
- 5.23 ± 11.24 | 0.143 |
| DBP |
81.63 ± 11.24 |
80.43 ± 6.87 |
- 1.2 ± 10.25 |
0.062* | 80.45 ± 10.23 |
79.69 ± 9.98 |
- 0.76 ± 10.54 |
0.239 |
| HR |
76.61 ± 10.21 |
69.26 ± 7.76 |
- 7.35 ± 9.21 |
0.041 | 76.81 ± 11.23 |
71.68 ± 5.67 |
- 5.13 ± 2.98 | 0.042$ |
| RR | 17.82 ± 1.30 | 16.48 ± 0.78 |
- 1.34 ± 0.12 |
0.041 |
17.80 ± 1.34 |
16.82 ± 6.98 |
- 0.98 ± 2.14 |
0.214 |
| Spo2 |
96.65% ± 1.78 |
97.98% ± 1.96 |
+ 1.33% ± 0.25 | 0.032 | 96.22% ± 2.89 | 96.78% ± 0.87 | + 0.56% ± 0.29 | 0.367 |
| MDAS |
7.43 ± 0.121 |
5.22 ± 0.54 | - 2.21 ± 0.13 | 0.012 |
7.73 ± 0.15 |
7.30 ± 0.98 |
- 0.43 ± 0.21 |
0.340 |
| STAI |
75.54 ± 10.65 |
70.84 ± 9.91 |
- 4.7 ± 8.60 | 0.011 | 76.58 ± 11.12 |
76.02 ± 0.87 |
- 0. 56 ± 0.43 |
0.653 |
| Pain score | 89.78 ± 1.23 |
80.96 ± 0.87 |
- 8.82 ± 3.34 | 0.023 | 93.21 ± 2.23 |
90.84 ± 4.76 |
- 2.37 ± 0.67 |
0.087 |
SD Standard Deviation, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, HR Heart Rate, RR Respiratory Rate, Spo2 Oxygen saturation, MDAS Modified Dental Anxiety Scale, STAI Speilberger State-Trait Anxiety Inventory, VAS Visual Analog Scale
*Not Significant
$Significant